Recommendations for Treatment as Prevention Among Heterosexual HIV Discordant Couples: A South African Case Study by Greene, Kelli
Recommendations for Treatment as Prevention Among  
Heterosexual HIV Discordant Couples: A South African Case Study 
 
 
By 
Kelli M. Greene 
 
 
A Master’s Paper submitted to the faculty of 
the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for  
the degree of Master of Public Health in 
the Public Health Leadership Program 
 
 
 
Chapel Hill 
 
Spring 2014 
 
 
 
 
  
        
        
 Advisor: William A. Sollecito, DrPH   
                                      
 
Date 
 
 
       
 
Second Reader: Lynn Morris, PhD   
  
 
Date 
 
 
 
 
2 
 
Abstract 
The Human Immunodeficiency Virus (HIV) epidemic remains a major public health 
crisis even after thirty years of research. Despite great strides in the prevention and treatment of 
HIV-infected individuals, sexual transmissions continue worldwide and especially in sub-
Saharan Africa (UNAIDS, 2013). Moreover, the increasing presence of heterosexual HIV 
discordant couples, where one partner in the couple is HIV-positive and the other is HIV-
negative, presents unique challenges. Low perceptions of HIV risk and inadequate prevention 
strategies among this subpopulation fuel sexual transmissions. The WHO and UNAIDS 
recommend that targeted strategies be applied systematically which effectively treat the infected 
partner for his/her own health but also prevent HIV transmission to the uninfected partner 
(WHO, 2012). The proposed modality for accomplishing this task in this subpopulation is known 
as “treatment as prevention.” The landmark HPTN 052 trial where the infected person received 
HIV antiretroviral therapy (ART) early in infection, which suppressed HIV and protected the 
infected person’s immune system, but also reduced HIV transmission to the uninfected partner, 
confirmed this was as a promising method for reducing HIV incidence among discordant couples 
(Cohen et al., 2011). Harnessing information learned from discordant couples’ studies, 
recommendations are presented as part of a comprehensive treatment as prevention program 
tailored to this subpopulation. These global recommendations include couples testing and 
counseling, condom education, education about and access to ART, and use of social marketing 
for implementation and optimal results. These recommendations are evaluated for their potential 
benefits in the context of a South African Case Study given South Africa’s prominence in the 
HIV/AIDS epidemic, the significant presence of discordant couples and the South African 
government’s commitment to HIV treatment and prevention efforts. Moreover, the South 
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African Case Study establishes the feasibility of the recommendations and helps to identify 
barriers that need to be overcome. Finally, a discussion of future research needed is presented for 
further optimization of the proposed treatment as prevention strategy. 
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Glossary of Terms 
AIDS Acquired Immunodeficiency Syndrome 
ANC Antenatal care 
ART Anti-retroviral therapy, A treatment for controlling HIV 
comprised of three or more anti-retroviral (ARV) drugs 
ARV Anti-retrovirals 
CBO Community based organization 
CD4+ T cells White blood cells that orchestrate immune responses; also 
known as T helper cells.  
CHTC Couples HIV testing and counseling 
FBO Faith based organization 
HTC HIV testing and counseling (focus on individual to be tested) 
HIV  Human Immunodeficiency Virus 
HIV Incidence The rate of new HIV infections, usually measured as the rate of 
persons who become newly infected with HIV 
HIV-Negative A person who is not infected with HIV 
HIV-Positive A person infected with HIV 
HIV Prevalence The proportion of the population who are HIV positive at any 
given time point 
HIV Serodiscordant Couple A partnership whereby one partner in the couple is HIV-positive 
and one partner in the couple is HIV-negative; also known as 
“discordant couples” 
Immune deficiency Inability of immune system to work properly, resulting in 
susceptibility to disease 
Immunosuppression Immune system response to foreign invaders is reduced 
Index Case The HIV-infected partner in a serodiscordant couple 
IPV Intimate partner violence 
PHDP Positive health, dignity and prevention; a movement which 
encourages PLHIV to live healthy lives and prevent further HIV 
transmissions 
PLHIV People living with HIV/AIDS 
PMTCT Prevention of mother-to-child transmission of HIV 
Replication Process by which a virus makes copies of itself 
VCT Voluntary counseling and testing 
Viral Load A measure of the amount of HIV in the blood of an infected 
individual 
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Introduction 
Human Immunodeficiency Virus (HIV), the virus that causes Acquired 
Immunodeficiency Syndrome (AIDS) in humans, remains an unresolved public health issue and 
the world’s leading infectious killer with an estimated 36 million deaths since the epidemic 
began (World Health Organization [WHO], 2013b). Currently there are over 35 million people 
living with HIV/AIDS (PLHIV), indicative of the success of antiretroviral therapy (ART) in 
suppressing although not curing HIV, and slowing progression to AIDS. The ability to treat HIV 
infection is critical but stopping new infections to eliminate HIV remains a critical public health 
issue. Towards this end, in 2000 the United Nations acknowledged the critical need for an 
effective response to HIV/AIDS in the Millennium Declaration and set a target to reduce the 
sexual transmission of HIV by 50% by 2015 (UNAIDS, 2013). Although the HIV incidence rate 
decreased approximately 50% in 25 countries during 2001-2011 due to HIV prevention 
interventions, 2.5 million new infections occurred in 2011 alone (Cohen et al., 2013).  
Moreover, it is estimated that 70% of all new infections occur disproportionately in sub-
Saharan Africa; nearly 1 in every 20 adults in this geographic region are infected with HIV 
(UNAIDS, 2013; WHO, 2013b). One sub-Saharan Africa country, the Republic of South Africa, 
has experienced the greatest burden of HIV/AIDS with an estimated overall prevalence of 10%, 
and the largest population of PLHIV, and an estimated one out of every six PLHIV worldwide 
calling South Africa home (South African National AIDS Council [SANAC], 2011).  
The WHO reports that there is increasing evidence that a substantial proportion of new 
HIV infections fueling the epidemic, both in sub-Saharan Africa and globally, occur within 
heterosexual, HIV serodiscordant couples, also described as “discordant couples” (2012). HIV 
discordant couples are defined as a partnership whereby one partner is HIV-positive and one 
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partner is HIV-negative (UNAIDS, 2013). Discordant couples represent a large subpopulation of 
PLHIV but have largely been under targeted in prevention and treatment efforts (Gay et al., 
2012). In most sub-Saharan African countries, 75% of adults (aged 20-49 years) report being in 
stable cohabiting or married relationships, and for every PLHIV in a co-habiting couple, nearly 
half report a HIV-negative partner (WHO, 2012). Moreover, the majority of individuals in stable, 
cohabiting relationships do not know their own and/or their partner’s HIV infection status or do 
not believe they are at risk for HIV infection. For those who do know their own and/or their 
partner’s HIV infection status, they do not understand the concept of discordance and that they 
can prevent HIV transmission to their uninfected partner (WHO, 2012). UNAIDS emphasizes 
the critical need for discordant couples to be targeted with an effective HIV prevention strategy 
given the substantially increased risk for the uninfected partner to acquire HIV from his/her 
infected partner due to these reasons and the frequency of their sexual intercourse events (2013). 
The question remains how; what constitutes an effective, efficient and affordable intervention 
and how should an intervention be delivered to these couples in a way which encourages 
significant uptake and better health outcomes? 
A potential solution for the subpopulation of heterosexual discordant couples is the 
concept of “treatment as prevention,” a method of treating PHLIV with ART for HIV 
suppression, for the sake of their own health, but whereby they also receive extensive counseling 
and other behavioral interventions, to prevent HIV transmission to their uninfected partner 
(AVERT, 2014). This concept was demonstrated as a viable prevention modality among this 
subpopulation in the HIV Prevention Trial Network’s landmark clinical trial as described below 
(Cohen et al., 2011). Although the findings are relatively new and additional research is needed, 
many in the HIV/AIDS field, including the WHO and UNAIDS, have put forth the concept of 
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treatment as prevention as a promising strategy for heterosexual, discordant couples in stable 
relationships. Critically, targeting this particular subpopulation affords an opportunity to increase 
HIV testing and counseling, support the infected partner’s ART treatment and decrease HIV 
transmissions to the uninfected partner (WHO, 2012). 
Goals of This Paper 
To further explore this issue, this paper will present background information on 
HIV/AIDS, an overview of discordant couples and why many HIV prevention efforts are not 
reaching them and a review of the role of ART in treatment as prevention strategies. 
Recommendations for a proposed treatment as prevention approach among heterosexual 
discordant couples will be presented including targeted couples testing and counseling, condom 
education, education about and linkages to ART, and use of social marketing to be leveraged for 
optimal results. These recommendations will be examined in a general context but also 
specifically within the context of South Africa, which will be used as a case study given its 
prominence in the HIV/AIDS epidemic, the significant proportion of PLHIV in discordant 
relationships and the South African government’s commitment to HIV prevention and treatment. 
The application of recommendations to the South African Case Study will be assessed to 
evaluate the potential benefits and potential barriers of this approach. Finally suggestions 
regarding future directions for research and practice will be presented. 
HIV/AIDS 
History of HIV/AIDS 
The history of the HIV/AIDS epidemic is well documented in both scientific and public 
health literature. In the June 5, 1981 issue of the Morbidity and Mortality Weekly Report 
(MMWR) published by the Centers for Disease Control and Prevention (CDC) physicians 
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described the appearance of a mysterious, emerging infectious disease affecting previously 
healthy homosexual men in the United States. By 1982, the CDC had named the disease, which 
caused immunodeficiency, “AIDS” with documented cases expanding to also include 
heterosexual females, hemophiliacs, injection drug users, and Haitians (US DHHS, 2011). The 
landmark edition of the MMWR, and the case reports which followed over 30 year ago, are 
associated with the beginning of the HIV/AIDS epidemic we know today. 
Biology & Transmission of HIV 
HIV belongs to the virus family Retroviridae and the genus Lentivirus with lentiviruses 
being characterized by a substantial period between initial infection and observation of disease 
symptoms (National Institute of Allergy and Infectious Diseases [NIAID], 2012). HIV targets the 
host’s CD4+ T cells; HIV utilizes the host cell’s machinery to replicate with new virus particles 
released via budding through the host cell’s membrane, which kills the CD4 cell. This replication 
cycle repeats over and over. Many of the antiretroviral drugs (ARV), which will be described 
later in further detail, work by disrupting this replication process (NIAID, 2012).  
 HIV spreads through body fluids and blood and is most commonly transmitted among 
adults via unprotected sexual intercourse with an infected person (CDC, 2013a). Although more 
rare, the virus can also be spread through oral sex (NIAID, 2012). Some HIV infections occur 
through contact with infected blood or equipment, e.g., sharing needles during intravenous drug 
use, accidental needle sticks in health care settings or infusion of contaminated blood with the 
latter being less likely in the developed world due to the advent of stringent screening processes. 
The most likely transmission route among HIV-infected children includes vertical transmission, 
either antenatal (before birth), perinatal (during birth) or postnatal (after birth), or during 
breastfeeding. HIV testing, counseling and ART are all key components for preventing mother-
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to-child transmissions (PMTCT) (NIAID, 2012). Across transmission modes, evidence suggests 
the likelihood of transmission correlates positively with the concentration of HIV in the 
transmitting individual (Cohen & Gay, 2010).    
Clinical Stages of HIV Infection 
HIV infection can be characterized by three clinical phases termed acute infection, 
clinical latency, and AIDS. The acute infection period is defined as within two to four weeks 
post infection, whereby most individuals do not know they have been infected with HIV, but up 
to 70% experience flu-like symptoms due to the immune’s system natural response to infection 
(NIAID, 2012). During this phase, large amounts of HIV particles are being produced and 
circulating in the blood, as measured by viral load. Likewise, large numbers of CD4+ T cells are 
being destroyed through this viral replication process (CDC, 2013a). The CD4+ T cells are a 
critical component of the host’s immune system, so disruption of their function is devastating. It 
is during this period of high viral load that transmission risk is the highest. Towards the end of 
this phase, the immune system begins to decrease the amount of virus present and the CD4 cells 
begin to recover although not to the same pre-infection level (NIAID, 2012).  
Following is the clinical latency period where HIV is active but reproducing at low 
levels. Phase duration varies depending on whether and when individuals initiate ART as 
described later in further detail. Critically, individuals are still able transmit HIV during this time 
(CDC, 2013a). Towards the end of this stage, untreated infected individuals simultaneously 
experience an increase in viral load and decline in CD4 cell count. The immune system weakens 
and individuals present with symptoms of HIV infection (WHO, 2013a). 
In untreated individuals, the clinical latency period is followed by AIDS, the final stage 
of infection which is characterized by immunodeficiency and is defined by the occurrence of any 
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of more than 20 opportunistic infections, e.g., Pneumocystis carinii pneumonia (PCP), and a 
CD4 cell count ≤ 200 cells/µl of blood, as compared to 500-1,600 cells/µl observed in uninfected 
individuals (CDC, 2013a). Individuals with AIDS typically suffer from debilitating weight loss, 
infections of various organs and cancers, e.g., Kaposi’s sarcoma. In the absence of treatment, 
individuals in this stage have a typical life expectancy of one to three years depending on the 
severity of their opportunistic infections (CDC, 2013a).  
Heterosexual HIV-Serodiscordant Couples  
 
As previously described, heterosexual discordant couples represent an important 
subpopulation contributing to new HIV infections and one that requires different prevention 
education and intervention strategies as those applied to individuals. Current data from sub-
Saharan countries reveal that one-half to two-thirds of HIV-positive individuals in stable 
heterosexual relationships have an uninfected partner (Management Sciences for Health [MSH], 
2012). As early as 2003, surveillance data indicated the majority of new HIV infections in sub-
Saharan Africa were occurring between cohabiting couples (Allen et al., 2003).  
One factor influencing these new infections is evidence suggesting the partners are 
unaware of their own HIV infection status, and if known, do not share this information with their 
respective partners. A 2008 study in South Africa revealed that men in long term partnerships 
rarely discuss HIV testing or infection status with their female partners, a finding which is 
common in many African countries. If their partner’s status is known, often men assume their 
share the same HIV infection status or wait “to learn their status” until their female partner 
becomes pregnant and is tested for HIV during antenatal care (ANC) as part of PMTCT 
programs (Mindry et al., 2011). Even when the partners know he/she is infected, he/she is often 
reticent to disclose this information to their partner due to fear and the threat of stigma, 
discrimination, intimate partner violence (IPV) and relationship termination (MSH, 2012).  
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The HIV-infected partners within the discordant couples, termed index cases, comprise a 
large segment of the HIV-infected population, and the couples represent a subpopulation which 
should be targeted for HIV prevention interventions. However, the WHO reports the concept of 
“discordance” and the large presence of these couples are generally overlooked or poorly 
understood in many communities worldwide (2012). For this reason, discordant couples are often 
overlooked entirely or targeted with traditional HIV prevention strategies, which are successful 
for other subpopulations, but are largely ineffective among this subpopulation.  
Traditional HIV prevention strategies focus on HIV testing, abstinence and/or consistent 
condom use, all of which tend to have low compliance among long-term, heterosexual couples 
given their predominant perception of low HIV risk (MGH, 2012). Medical male circumcision, a 
proven biomedical intervention for significantly reducing new HIV infections in males, has been 
widely promoted but does not directly address risk among females (WHO, 2012). One particular 
strategy, voluntary counseling and testing (VCT), or individual-initiated testing with counseling, 
has contributed significantly to increased HIV testing, condom use and reduced transmissions 
(Gay et al., 2012). However, this type of testing focuses on the individual and does not guarantee 
or support disclosure to the individual’s partner. Moreover, concerns about IPV following 
disclosure in the absence of couples counseling make VCT sub-optimal (WHO, 2012).  
When couples have been considered, HIV prevention efforts have focused primarily on 
encouraging elimination of males’ use of sex workers and/or concurrent partners. Likewise, 
associated social marketing has been aimed at addressing issues of male domination of females 
and encouraging female empowerment to facilitate more open discussion about sex and HIV 
(Eyawo et al., 2010). These practices suggest there’s an underlying assumption that the index 
case within the discordant couple is usually the male. However, research indicates that females 
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are equally as likely to be the index case in most countries (Eyawo et al., 2010). When the male 
is the index case, he often does not know he is infected; if he does know, his female partner may 
be overlooked for targeted HIV testing, counseling and treatment until she accesses health care 
during pregnancy, triggering a PMTCT intervention. Access to HIV prevention strategies at this 
point represents a missed upstream prevention opportunity (WHO, 2012).  
For these reasons, this subpopulation of heterosexual discordant couples requires an 
approach for preventing HIV transmission between partners which differs from traditional 
approaches. In absence of consensus about the best way to target this subpopulation, there is 
general agreement that ART is a critical component of any solution (WHO, 2012).      
ART a Major Treatment as Prevention Tool 
What is ART?  
As previously mentioned, HIV can be suppressed in infected individuals through the use 
of a combination antiretroviral therapy (ART) which is comprised of a “cocktail” of three or 
more antiretroviral (ARV) drugs (WHO, 2013a). The first ARV drug, zidovudine or AZT, was 
licensed by the US Food and Drug Administration (FDA) in March 1987; however, this 
treatment and others in the early years had problems with toxicity and adherence due to drug 
formulation, dosage, frequency and access issues (US DHHS, 2011). By 1996, companies had 
developed combination ART, and these drugs are divided into five classes based on how they 
target and disrupt the HIV replication life cycle (Johnson, 2012). As of 2012, there were 25 
drugs available, with demonstrated reduced side effects and improved ease of use (CDC, 2013b).  
World Health Organization’s Guidelines on Initiation of ART 
 
The 2010 WHO guidelines recommended that HIV-positive adults initiate ART once 
their CD4 counts reach ≤ 350 cells/µl (2013a). However, in 2013 the guidelines were revised to 
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recommend ART initiation at a higher CD4 level (≤ 500 cells/µl). This revision is due to a recent 
study, as described later, which demonstrated that earlier initiation of ART by HIV-infected 
individuals is beneficial for their own health. Beyond the health benefits to the HIV-infected 
individual, this same study also demonstrated that ART treatment of the infected individual 
reduced the risk of transmitting HIV to his/her partner. For this reason, the 2013 WHO 
guidelines now recommends ART for HIV-positive individuals in discordant relationships, 
regardless of their CD4 level (2013a). Finally, the 2013 guidelines recommend ART, regardless 
of CD4 count, to HIV-positive children under five years, HIV-positive pregnant or breastfeeding 
females, and all HIV-positive individuals with active tuberculosis or hepatitis B (2013a).  
How Does ART Work as Treatment in HIV-Infected Individuals? 
When utilized as directed, ART is a highly efficacious method for treating HIV-infected 
individuals which protects their health and delays onset of AIDS. ART suppresses but does not 
eliminate HIV by interfering with HIV replication, thus decreasing the virus concentration in the 
blood (viral load) and genital secretions. Early initiation of ART results in a reduced latent viral 
reservoir, meaning there is less virus present in the infected individual as compared to someone 
who initiates ART at a lower CD4 count (Cohen et al., 2013). This significant reduction in viral 
load preserves the CD4 cells and their immune function, thereby safeguarding of the immune 
system to fight ordinary infections (NIAID, 2012). 
Prior to the advent of ART in the mid-1990’s, individuals often progressed to AIDS 
within a few years; today, infected individuals who initiate ART early and receive proper 
medical care can control the virus and experience a prolonged and often near normal life 
expectancy (CDC, 2013a). Moreover, ART treatment of PLHIV reduces the amount of virus 
circulating in the population which reduces HIV incidence rates. UNAIDS estimates 6.6 million 
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AIDS-related deaths worldwide have been averted due to ART (2013). Despite these advantages, 
ART as an effective treatment of HIV-infected individuals requires that people know their HIV 
infection status, strictly adhere to their regimen and maintain access to health care.  
ART Treatment as Prevention of HIV  
In the absence of a vaccine and the inability of behavioral modifications to eliminate HIV 
transmission, HIV/AIDS researchers and practitioners began investigating whether the 
aforementioned benefits of ART for individuals could be translated into a potential preventative 
tool against sexual transmission of HIV to others (WHO, 2012). The CDC defines this concept, 
known as treatment as prevention, as “a strategy for treating HIV-infected persons to improve 
their health and to reduce the risk of onward transmission” (2013b, pg. 1). The treatment as 
prevention concept is not a new practice; it has been in wide use since the mid-1990’s but aimed 
at pregnant women to prevent HIV transmission to their children during pregnancy and 
breastfeeding (AVERT, 2013). Discordant couples comprise a specific subpopulation which 
could clearly benefit from such a strategy. 
Evidence from several studies supports that transmission risk increases as viral load 
increases (Cohen & Gay, 2010). Observational data, ecological studies and modeling suggested 
decreased transmission of HIV from infected partners on ART to their uninfected partners but 
definitive proof was lacking (Cohen et al., 2011; Anglemyer et al., 2011). However, it was the 
landmark HPTN 052 trial, as described below, which galvanized treatment as prevention as a 
relevant strategy for preventing heterosexual transmissions within discordant couples.  
The HPTN initiated this randomized, controlled clinical trial termed “052” in 2005, 
which included 1,763 discordant couples in stable, heterosexual relationships, across 13 sites in 
nine countries including South Africa. The study hypothesized whether ART, proven to reduce 
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viral replication, could limit HIV transmission within these discordant couples (Cohen et al., 
2011). Moreover, the trial compared early versus delayed initiation of ART for HIV-infected 
participants. All study participants were part of a discordant couple with the HIV infected 
individuals having CD4 counts between 350-550 cells/µl and no history of ART (with the 
exception of short-term use for PMTCT). The study protocol employed a randomization scheme 
to assign half of the HIV-infected participants to the early-therapy group for immediate initiation 
of ART at enrollment. The other half of HIV-infected participants were assigned to the delayed-
therapy group where their treatment was delayed until their CD4 counts were ˂ 250 cells/µl or 
they developed an AIDS-related illness (Cohen et al., 2011). Following enrollment, trial 
participants attended three monthly visits, followed by quarterly visits. During these visits, the 
participants and their partners received joint counseling regarding HIV education, risk reduction, 
condom usage, STI treatment and management of other medical conditions. The uninfected 
partners were tested for HIV on a quarterly basis. The primary prevention endpoint was linked 
HIV transmission in uninfected partners, meaning that if a transmission occurred, clinicians 
could confirm the index case in the couple transmitted their virus to the previously uninfected 
partner using comparative sequence analysis techniques (Cohen et al., 2011).  
The HPTN 052 trial is scheduled for completion in 2015 with original plans to compare 
the groups at that time. However, in April 2011 an independent monitoring board for the trial 
recommended that the trial results be made public; the trial had demonstrated that if an HIV-
infected partner in a heterosexual, discordant couple was counseled and adhered to an effective 
ART regimen early in infection, there was observed suppression of HIV viral levels in the genital 
tract of the infected partner (Cohen et al., 2011). Consequently the risk of sexually transmitting 
the virus to their uninfected partner was reduced by 96%. In total, 39 transmissions were 
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observed and 28 were virologically linked meaning the viral sequence in both the index case and 
newly infected partner were almost identical. Notably, of these 28 linked transmissions, only one 
transmission event was observed in the early treatment arm suggesting the early initiation with 
ART contributed to the observed decrease in transmission risk. Finally, 11 of the transmission 
events were not virologically linked meaning that the index case in the couple did not infect their 
previously uninfected partner, but rather that the newly infected partner acquired HIV through 
someone external to the relationship (Cohen et al., 2011). The implications of this latter finding 
suggest that in addition to ART therapy, there remains a critical need for education and 
counseling regarding risk reduction behaviors, such as discouraging multiple sexual partners and 
using safe sex practices, for the prevention of HIV infection.     
The results of this trial demonstrated that ART as treatment as prevention, in this specific 
subpopulation of heterosexual discordant couples, along with couples counseling and HIV 
education, was efficacious for drastically reducing HIV transmissions. Science, one of the 
world’s leading scientific journals, named the HPTN 052 as “Breakthrough of the Year” and 
many called the results a complete “game changer” due to the nearly 100% efficacy observed 
(Cohen, 2011). Prior to proving treatment as prevention worked in this subpopulation, the 
primarily emphasis of ART treatment focused on benefits to the HIV-infected individual rather 
than the additional benefit of preventing transmission to the uninfected partner. As previously 
described, the results also prompted the WHO to revise their guidelines to include earlier 
initiation of ART by HIV-infected individuals for their own health, but also initiation of ART by 
HIV-infected individuals in discordant relationships to provide potential protection from HIV 
transmission to their uninfected partner. Finally, in 2012 the WHO also issued a set of guidelines 
addressing treatment as prevention in discordant couples (2012).   
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Access to ART Globally  
 
A critical component of any ART treatment strategy is access to ART. This is true for 
treatment of individuals and for treatment as prevention strategies for discordant couples. These 
drugs are so vital in the battle against HIV that in 2000 the United Nations set a Millennium 
Development Goal to provide ART to 15 million PLHIV by 2015 (UNAIDS, 2013). In 2012, 
more than 9.7 million PLHIV in low and middle income countries received ART (WHO, 2013b). 
These statistics represent a nearly 30-fold increase in the number of people receiving ART in 
developing countries during 2003-2012, and close to a 20% increase during 2011-2012 alone. 
However, key issues regarding access and affordability of ART remain and need to be addressed. 
As of 2010, it was estimated that for every one PLHIV receiving treatment, another four PLHIV 
need it (Cohen & Gay, 2010). Under the new 2013 guidelines, an estimated 29 million PLHIV 
were eligible to initiate ART, indicating only 34% of now eligible PLHIV were receiving ART. 
Continued rapid scale up is needed to ensure adequate coverage (UNAIDS, 2013).   
Recommendations 
The review presented in the previous section outlines why heterosexual discordant 
couples constitute an important subpopulation in urgent need of targeted HIV treatment as 
prevention strategies to benefit both the infected and uninfected individuals in the partnership. 
The recommendations which follow aim to address the previously described factors which 
contribute to transmission risk between the partners. In summary, these factors include:  
• Lack of knowledge regarding HIV infection status  
• Unwillingness to disclose HIV infection status 
• Poor or no understanding about discordance 
• High frequency of sexual intercourse events within discordant couples 
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• Absence of and/or inconsistent condom usage 
• Lack of knowledge, access and adherence to ART for the index case 
• General stigma, fear and lack of support to address HIV within their relationships  
The following recommendations also seek to provide appropriate channels and mechanisms for 
this subpopulation to receive the proposed treatment as prevention intervention in a way that is 
relevant and tailored to them. Finally, these recommendations should be implemented as a 
comprehensive treatment as prevention program for optimal results.   
1. Increased Access to Couples HIV Testing & Counseling (CHTC) with Support for 
Mutual Disclosure and Education Regarding Discordance 
 
 Global consensus remains that access to knowledge of HIV infection status through 
testing and counseling methods is critical to expanding access to treatment, support and 
information and to prevent further transmissions (Gay et al., 2012). CHTC provides an 
opportunity for couples to receive condoms, information on HIV and discordance, understand 
their risk, to test and share their status with one another in a guided and safer environment, and 
learn how condoms and ART can be utilized to treat HIV and prevent transmission within their 
relationship (Kelley et al., 2011). All CHTC regardless of setting should provide linkages to 
access to ART for discordant couples (Kennedy et al., 2011). Moreover, CHTC is the central 
entry point for accessing the collective set of recommendations delivered as an intervention 
package and facilitates adherence to the intervention. Finally, the WHO recognizes the critical 
role of CHTC in treatment as prevention interventions for discordant couple and developed 
guidance on the best methods for delivering it (2012).  
2. Increased Access, Education and Emphasis on Condom Usage for Long Term Couples 
USAID indicates that programs which promote correct condom usage are integral to any 
effective HIV program (2013b). This recommendation is critical given research suggests that 
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long term heterosexual couples are less likely to use condoms due to their perceived low risk for 
HIV. Messaging about consistent condom usage among long term couples and in the context of 
discordance is needed (Kennedy et al., 2010). Studies report condom use among discordant 
couples increased following effective CHTC (Kennedy et al., 2010; Allen et al., 2003).  
3. Increased Access to ART for Discordant Couples in Accordance to 2013 WHO 
Guidelines 
 
The “game changing” results from HPTN 052 and revised WHO guidelines leave no 
doubt that ART as treatment as prevention in discordant couples is strongly advisable for the 
health and stability of the individuals in the couple unit (WHO, 2012). It is critical that 
discordant couples have access to ART to prevent new transmissions. Many countries have made 
great strides to ensure that HIV-infected individuals have access to ART. However, with the 
previously described revisions to the WHO guidelines, more PLHIV will need access to ART. 
The WHO has indicated that in cases where both HIV-infected individuals and discordant 
couples both meet the guidelines for ART initiation but supply shortages exist, HIV-infected 
individuals should be given priority access (2012). In addition to price and supply related access 
issues, the index cases in discordant couples need to be able to access clinics where they can 
continue to maintain access to ART and be monitored sufficiently for optimal adherence to the 
prescribed regimen (WHO, 2012). Finally, it should be noted that some studies have indicated 
that ART may be advisable for the HIV-negative partner as well, but for the purposes of this 
review, the provision of ART will be specific to the HIV-infected partner. 
4. Increased Education Regarding ART and Promotion of Treatment as Prevention for 
Discordant Couples  
 
Discordant couples also should be thoroughly educated on ART’s HIV prevention power 
and what the concept of treatment as prevention entails; specifically, the infected partner’s strict 
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adherence to the prescribed ART regimen, faithfulness and safe sex practices between the couple 
and continued treatment and monitoring of the infected partner and HIV testing for the 
uninfected partner (WHO, 2012).  
5. Utilization of Social Marketing for Enhancing Implementation of Recommendations 
A final recommendation is to utilize social marketing for facilitating acceptance, 
delivery, and compliance to a treatment as prevention program. Social marketing is a collective 
set of strategies which can be applied to enhance public health interventions. Kotler & Zaltman 
define social marketing as “the design, implementation, and control of programs calculated to 
influence the acceptability of social ideas and involving considerations of product planning, 
pricing, communication, distribution, and marketing research” (1971, pg. 5). Engaging in social 
marketing activities facilitates enhanced understanding of target audiences including their 
environments, values, beliefs and constraints. Once these elements are understood, programs can 
apply social marketing, which harnesses the four classic commercial marketing strategies of 
product, price, place and promotion and combine them in a synergistic way to encourage 
adoption of this desired behavior by reducing barriers, increasing benefits and utilizing 
facilitators (Newton-Ward, 2013b). For example, the increased sales and reported utilization of 
condoms marketed for the prevention of HIV in sub-Saharan Africa is a well-documented 
example of the power of social marketing (Sweat et al., 2012).  
While critical to the implementation of a successful treatment as prevention program, a 
complete social marketing plan is beyond the scope of this paper. The specific details of how to 
perform social marketing are complex and require extensive research and associated financial 
support. However, a brief outline of proposed social marketing strategies applied in the context 
of the South African Case Study, as described below, is presented in the Appendix.  
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A South African Case Study for Translating Recommendations into Practice 
 
The collective recommendations for a comprehensive treatment as prevention strategy for 
heterosexual discordant couples presented here are relevant to many global settings. However, 
since the recommendations are fairly broad, there will be challenges implementing them 
worldwide on a large scale due to logistical and financial obstacles and the recommendations 
may be more readily implemented in specific countries. Moreover, the inclusion of social 
marketing strategies dictates a tailored approach. For these reasons, it is advantageous to discuss 
the application of these recommendations, such as anticipated benefits and barriers, using a 
specific country as a case study as well as for considering how social marketing can highlight 
benefits and reduce barriers to facilitate compliance as presented in the appendix. For this 
purpose, the Republic of South Africa is presented as a case study given its predominant role in 
the HIV/AIDS epidemic, a large presence of discordant couples, and the government’s 
demonstrated leadership and commitment to HIV prevention and treatment efforts.  
South Africa remains one of the hardest hit countries in the global HIV/AIDS epidemic. 
South Africa has approximately 5.26 million PLHIV among its population of approximately 53 
million people (Statistics South Africa [Stats SA], 2013). The size and nature of the South 
African HIV epidemic make addressing this public health issue a daunting but necessary 
challenge. Estimates suggest only 25% of South Africans have had a HIV test (CDC, 2012). 
However, estimates in 2009 indicated that over 1,000 South Africans are infected with HIV each 
day, with the majority occurring via sexual transmission (SANAC, 2011).   
South Africa’s commitment and successful efforts during the last decade to expand 
access to HIV prevention and treatment services, including ART, make it an ideal case study for 
implementation of the treatment as prevention strategy. The South African government leads a 
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universal HIV treatment program, which is administered through the public health system with 
new policies and infrastructure to offer HIV testing and services at local health clinics, making 
access to a variety of services and ART more feasible (Beaubian, 2013). This highly coordinated 
and systematic approach to treating HIV is critical given estimates that 15.9% of the adult 
population aged 15-49 years is HIV-positive (Stats SA, 2013).  
UNAIDS reports that South Africa leads the world in expanding access to ART with 
greater than 80% of eligible adults receiving ART in 2012, indicative of a 27% increase in 
provision as compared to 2011 (UNAIDS, 2013). In South Africa, ART access issues related to 
price should not be an issue given the government provides ART to nearly 2.15 million PLHIV 
every day for free or very low cost due to price negotiations, subsidies and donations (Beaubian, 
2013). South Africa purchased $700M (USD) worth of fixed-dose ART regimens in 2012, 
reflecting a nearly 38% price reduction, as part of its long-term sustainability plan (UNAIDS, 
2013). As a result of commitment to treat PHLIV in areas with high HIV incidence and 
prevalence, such as the KwaZulu-Natal province of South Africa, life expectancy increased by 
11.3 years between 2003-2011 following the ART scale-up in 2003 (Tanser et al., 2013). 
Clearly, South Africa serves as a model for addressing the price, supply and distribution 
dimensions of ART access. However, a challenging dimension of ART access remains; how to 
balance the prioritization of ART for infected individuals meeting CD4 count requirements 
versus those infected individuals who are part of discordant couples.  
South Africa is also a relevant country for studying discordant couples and implementing 
strategies aimed specifically at this subpopulation. In 2011, the South African government 
estimated the presence of at least 817,000 discordant couples (SANAC, 2011). South Africa, like 
many other African countries, experiences low marriage and cohabitation rates, and later age of 
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marriage; these factors influence the acceptability of multiple and concurrent sexual partners, 
and contributes to the increasing number of discordant couples. Moreover, with a large migrant 
population, often couples are separated for long periods of time which also significantly 
contributes to additional partners including transactional sex, new sexual transmissions and 
increasing discordancy (SANAC, 2011). Although these two issues may be more prevalent in 
South Africa as compared to other global settings, these issues are still relevant and must be 
addressed in treatment as prevention strategies for the couples.  
The previously presented issues facing discordant couples in other global settings, 
including their perceptions of low HIV risk and inadequate HIV prevention efforts, are also 
relevant to discordant couples in South Africa. Condom use remains relatively low among long 
term couples in general and females are equally as likely as males to be the index case in 
heterosexual discordant couples South Africa (SANAC, 2011). However, in terms of risk 
behaviors, studies in South Africa suggest that access to ART with increased testing and 
counseling results in behavior modifications to minimize HIV transmission risk among 
discordant couples (Johnson et al., 2012). Based on the large presence of discordant couples, 
South Africa has already initiated implementation of some CHTC on a limited basis and is 
investigating solutions to overcome barriers (Dilmitis, 2011; CDC, 2012).  
Finally, social marketing strategies have been utilized widely and effectively in South 
Africa for other HIV prevention modalities such as general HIV education, condom and lubricant 
usage, male circumcision, VCT and PMTCT to enable behavior modifications, all of which have 
been critical in decreasing HIV transmission rates (Johnson et al., 2012; Population Services 
International [PSI], 2013). In order to increase compliance, discordant couples need to believe in 
the benefits of  adhering to these treatment as prevention components, which include remaining 
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monogamous, consistently using condoms, receiving care, testing and counseling and using 
ART, protects their own health and drastically reduces risk their chances of HIV transmission to 
their uninfected partner (Smith et al., 2012). Issues with compliance to these strategies can be 
addressed using social marketing strategies to identify and overcome the root cause of these 
barriers (Newton-Ward, 2013a). This latter exercise is better facilitated in South Africa where 
social marketing for HIV prevention and treatment strategies are already widely in use.   
     Discussion 
Benefits Associated with Treatment as Prevention Recommendations 
 
The benefits associated with the collective treatment as prevention recommendations are 
numerous. The packaged message for discordant couples is that the treatment as prevention 
strategy among heterosexual discordant couples affords a life changing opportunity to avert 
transmissions if applied in the context of routine couples-based testing, counseling and support, 
safe intercourse practices, and adherence to ART regimens (CDC, 2013b). Once again, using 
South Africa as a case study provides a specific setting to assess these benefits. The literature 
indicates that many of these couples in South Africa do not know their individual HIV infection 
status or assume they share the same status and perceive their HIV risk is low risk given the 
nature of their relationship status; these couples do not see the utility of condoms for these same 
reasons and view HTC as an individual activity. These couples likely do not realize that effective 
ART treatment of the infected partner not only safeguards his/her health but also can prevent 
further transmission to his/her uninfected partner (WHO, 2012). For these reasons, it is critical to 
emphasize the benefits of adherence to these collective recommendations and convince couples 
that their participation is beneficial and necessary for their long term health and life stability.  
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CHTC is especially beneficial as it serves as an upstream intervention with many 
promising downstream behaviors which predict better health outcomes for both partners. South 
Africa acknowledges the powerful impact of CHTC and has engaged celebrity couples in 
marketing CHTC (SANAC, 2011). Effective CHTC by trained providers can positively influence 
the couples, regardless of marital status, by increasing partner cohesion and decreasing the threat 
and/or presence of IPV which can drive fear of testing and of sharing results (Gay et al., 2012). 
Data reveals more women than men are tested, thus resulting in women disparately bearing the 
burden of disclosure. More men testing via CHTC helps increase men’s knowledge of HIV, 
mitigates some IPV concerns and helps establish new social norms (Dilmitis, 2011). Published 
studies, including those in South Africa, suggest that once individuals learn their infection status 
and receive counseling, they are more likely to adopt preventive behaviors as compared to 
individuals who do not know their status (WHO, 2012). In addition, effective CHTC facilitates 
access to care and encourages early initiation and adherence to ART by the infected partner, 
improving that partner’s own health via decreased viral load and risk for drug resistance, 
preservation of CD4 cells and delayed onset of AIDS (Wong, 2013).  
Collectively, these treatment as prevention recommendations provides an opportunity for 
the HIV-positive partner to play a prominent role in prevention efforts, a critical component of 
the “positive health, dignity and prevention” movement (MSH, 2012). This intervention affords 
an opportunity for both safer family planning and conception and reductions in HIV incidence in 
infants (WHO, 2012). Several studies suggest that discordant couples are receptive to this 
information but healthcare workers do not routinely engage them in this discussion if not 
specifically asked (Matthews et al., 2012). CHTC can also serve as a decision point regarding 
male circumcision, another evidence based HIV prevention strategy (WHO, 2012). Notably, the 
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counseling portion of CHTC is especially critical; it serves as a channel for receiving quality 
education about HIV, support for PLHIV and decreasing stigma associated with HIV/AIDS 
within the partnership, their families and communities and (WHO, 2012).  
The benefits associated with condoms are well known as they are an efficient and 
affordable evidence based method for preventing sexual transmission of HIV (USAID, 2013b). 
South Africa has experienced great success with social marketing for increased usage of male 
condoms. Modeling suggests condoms contributed significantly to lower incidence rates 
observed during 2000-2008 (WHO, 2012). It is hoped that similar declines will be observed 
among discordant couples. A study in South Africa exploring contraception practices of HIV-
positive females on ART found they were more likely to utilize condoms if they knew their 
partners were uninfected, another promising benefit of these recommendations (Oni et al., 2013).  
Targeting heterosexual discordant couples with these recommendations may also provide 
enhanced opportunities for HIV-infected men to access ART. Data from sub-Saharan Africa in 
2012 suggested HIV treatment coverage for eligible males (57%) is much lower as compared to 
eligible females (73%), likely due to the large amount of HIV testing and treatment efforts 
focused on PMTCT (WHO, 2012). Ideally, targeting couples will result in more males being 
tested and initiating ART earlier. Moreover, more men being diagnosed and treated also drive 
down stigma which cripples women’s roles in prevention efforts (Gay et al., 2012).  
If the proposed treatment as prevention strategy is successful, a substantial number of 
new infections within this subpopulation could be averted. Among heterosexual discordant 
couples in South Africa, the literature reports an incidence rate of 1.48 transmissions per partner 
per 100 person-years, for individuals without suppression of HIV (Walensky et al., 2013). As 
previously described, the South African government estimated the presence of at least 817,000 
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discordant couples in 2011. In the absence of viral suppression in the index case, it’s reasonable 
to expect an estimated 12,092 linked transmissions in a given year. However, assuming the 
treatment as prevention strategy described here is as successful as the results observed in HPTN 
052, there’s potential to observe up to a 96% relative reduction in linked transmissions among 
this subpopulation (Cohen et al., 2011). If the 96% relative reduction in linked transmissions is 
applied to discordant couple subpopulation in South Africa, there’s the potential for averting 
11,608 linked transmissions in a given year. This estimate is for one year only such that over 
time more infections could be averted. Finally, this estimate assumes that the 96% relative 
reduction in linked transmissions observed in HPTN 052, which included multiple countries, can 
be translated from the clinical to a non-clinical setting specifically in South Africa. 
Moreover, the Cost-Effectiveness of Preventing AIDS Complications International 
Group’s analysis, designed to mirror the HPTN 052, suggests long term cost savings due to ART 
in South African discordant couples (Walensky et al., 2013). The five year survival rate among 
index cases increased to 93% with early initiation of ART, thus preventing opportunistic 
infections such as tuberculosis, the cause of death in 50% of all HIV-infected people (Walensky 
et al., 2013). Within five years, models suggest South Africa could experience cost savings via 
early initiation of ART in discordant couples as they stayed uninfected or healthier (Walensky et 
al., 2013). Economic analysis suggests that investment in services, such as those proposed, yield 
economic returns up to three times greater due to increased employment and productivity and 
averted or deferred future expenses for medical services and orphan care (WHO, 2012).  
Barriers to Implementation of Treatment as Prevention Recommendations 
 
 Although this set of recommendations is well-founded, discordant couples in South 
Africa and worldwide face barriers which could potentially discourage or prevent optimal 
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uptake. Several studies cite the most significant barrier preventing discordant couples from 
accessing testing and counseling is their perception of low HIV infection risk and a lack of 
knowledge about discordance (Gay et al., 2012). These recommendations are underpinned by the 
need for individuals to know their HIV infection status as early as possible, which as previously 
described, prompted the WHO to recommend that infected individuals with discordant partners 
should initiate ART regardless of their CD4 count. Access to general testing or the specific HIV 
test needed during acute infection can be challenging (Cohen & Gay, 2010).  
The concept of CHTC has been studied in many African countries and found to be an 
effective testing and counseling modality. However, estimates indicate less than 1% of couples 
used this joint service (Kelley et al., 2011). As previously discussed, many partners do not seem 
to understand the utility of CHTC given their perception that their infection status is the same or 
lack of knowing they can prevent transmissions within their partnership (Kelley et al., 2011). 
Barriers can be simple, e.g., lack of knowledge that CHTC services are available, or can be quite 
complicated. Studies reveal that partners are reticent to suggest couples testing due to fear of 
what the suggestion may imply or their partner’s reaction to a positive test result. This perception 
can be further exacerbated by relationship insecurity and challenges of maintaining long term 
relationships, both predominant issues within South Africa (Mindry et al., 2011).  
Barriers to accessing testing and counseling appear to be different among the female and 
male partners. The cited barriers for women generally include lack of time, monetary resources, 
transportation and childcare services to access services or lack of information that testing is 
necessary for them (Gay et al., 2012). Research indicates many women do not undergo testing 
due to fear of anticipated reactions following disclosure, which quite often includes abuse, moral 
judgment, relationship termination, discrimination and ostracism. Fear of IPV is a real concern in 
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South Africa where levels of gender-based violence are very high and often part of normal 
culture (Harrison et al., 2006). Studies document that females are often expected to initiate HIV-
related discussions despite their low negotiating power (Mindry et al., 2011). Studies indicate 
men often cite inconvenient hours of operation or location as reasons for not submitting to HIV 
testing and counseling. Men also tend to not access HTC via health services as they may not use 
health services at all for various reasons (Katz et al., 2009).  
Specific to couples testing, men often fear testing and disclosure of status to their long 
term partner if they already believe or know they are infected. Furthermore, men often fear they 
may have been infected due to short term affairs, with partners outside of their long term 
relationship (Gay et al., 2012). CHTC may be challenging given the physical separation of 
couples when one partner is a migrant worker or simply because they often are not married or 
cohabiting. CHTC is also more expensive and labor intensive than individual testing and studies 
of PMTCT have demonstrated that engagement of males can be difficult although male 
participation provides significant value added (SANAC, 2011).   
Another potential barrier is concern about increased sexual risk once couples realize ART 
decreases transmission risk. Some studies suggest individuals on ART are more likely to engage 
in riskier sexual behavior if they perceive their treatment prevents transmission (Cohen & Gay, 
2010). In contrast, other studies including one in South Africa, reported reductions in sexual risk 
behaviors after ART initiation, due in part to consistent prevention messaging. However, it is 
unclear if findings among individuals are relevant to discordant couples. Many clinicians suggest 
that perhaps these misconceptions and risks can be mitigated through long term clinical care and 
counseling of couples with an emphasis on safe sex practices (Venkatesh et al., 2011).   
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Future Directions for Research and Practice  
The recommendations set forth are based on studies among stable, heterosexual 
discordant couples which support ART as treatment as prevention among this subpopulation. 
However, questions remain if the treatment as prevention strategy will be efficacious in the 
subpopulation discussed here due to multiple components which seem to be required. Currently, 
it is unknown how significantly each component, e.g., CHTC, condom use, ART, and education, 
contributes to a successful treatment as prevention strategy; specifically, what is the expected 
outcome if one or more components are missing (Cohen et al., 2013). 
 Another more general question is whether or not the success observed in the controlled 
studies will translate into real world settings. This is an important question that is applicable to 
many new scientific breakthroughs and is being discussed in the implementation science 
literature but is beyond the scope of this paper to resolve (Bhattacharyya et al., 2009).  
Beyond these questions, future studies are needed on ART as a key component of 
treatment as prevention strategies. Although studies conclusively support that ART suppresses 
HIV, there is evidence that HIV suppression in the genital tract is incomplete; research indicates 
some individual components of ART do not penetrate genital secretions at all. Moreover, it is 
well documented that some individuals experience ARV drug resistance so the correct 
formulation, combination and strict adherence of ART is needed to ensure optimal performance 
of ART in treatment as prevention strategies (Cohen & Gay, 2010). Long term studies are 
needed to assess the impact of ART on HIV-infected individuals, the durability of their own drug 
induced HIV suppression, and the durability of protection against transmission within the context 
of modulating risk behaviors due to changes in risk perception over time (Anglemyer et al., 
2011). All these concerns will require frequent monitoring and counseling with the couples 
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(Cohen et al., 2013). Finally, it should be noted that some studies have indicated that ART may 
be advisable also for the HIV-negative partner, as a form of pre-exposure prophylaxis. This 
option should be further considered for greater efficacy and compared to value added in the 
context of ART cost and access issues (WHO, 2012). 
Other future considerations include how generalizable the findings of these studies will 
be among other subpopulations, e.g., less stable discordant couples and MSM (Cohen et al., 
2013). Beyond benefiting people on an individual or partnership level, future studies, such as the 
HPTN 071 trial being conducted in South Africa and Zambia, are needed to demonstrate ART’s 
utility as treatment as prevention on a population level (Smith et al., 2012). If results suggest this 
strategy is more relevant for specific subpopulation or within the context of specific 
environments, this could impact the roll out of these types of strategies including funding and 
access to ART given how many PLHIV need it (Cohen et al., 2013). Likewise, another new 
prevention strategy with possible potential is universal testing and treatment using ART. 
Although considered controversial, various modeling scenarios have suggested HIV can be 
eliminated in countries such as South Africa within a varying number of years by initiating 
annual HIV screening, initiating ART, and assuming a set uptake (Hontelez et al., 2013). This 
model negates the highly influential component of counseling so many opponents do not support 
this strategy. Although it seems likely that this strategy will not be suitable for discordant 
couples due to the absence of counseling, it should be considered (Gay et al., 2012).   
Another future area for additional research is reaching couples where one partner does 
know their HIV infection status and intentionally does not share it for the previously described 
reasons. Reaching these couples and getting them into CHTC is critical but will be especially 
challenging. Since the mainstream social marketing, which is aimed at couples who do not know 
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their HIV infection status, may be irrelevant for this group, additional research will be needed to 
determine how to best reach this important subpopulation. Another area for continued research 
linked to counseling is the continued long term support for couples. It should not be assumed that 
the same support system used to support individuals will be adequate for supporting couples. 
There are many cultural and socioeconomic factors influencing the couples in their daily lives 
but also in how they navigate life living with HIV.    
Conclusion 
 
In the 33 years since the first reported case of AIDS in the US, a diagnosis of HIV 
infection has transitioned from a death sentence to a more manageable chronic disease when 
infected individuals are able to access health care and ART (US DHHS, 2011). However, despite 
these improvements, HIV remains at epidemic proportions across much of the world, disparately 
affecting populations and disrupting families and socioeconomic functions, and remains cloaked 
in fear and stigma. Moreover, this paper highlights the fact that heterosexual transmissions are 
fueling new infections globally, including the large presence of discordant couples, and the fact 
that traditional prevention modalities may not be sufficient. Therefore, it is essential that 
countries address this under targeted subpopulation with effective prevention modalities.  
The paper presents a collective treatment as prevention approach which begins with 
increased access and promotion of CHTC, a focal point for the identification of discordant 
couples through HIV testing with support for mutual disclosure of test results. During CHTC, 
both partners can receive education about the concept of discordancy, and how ART can be used 
not only to treat the infected partner for the sake of his/her own health but also to prevent 
transmission to the uninfected partner. During the CHTC, discordant couples can also receive 
education about HIV, prevention efforts, and safe sex practices such as consistent condom usage. 
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In this treatment as prevention approach, discordant couples need increased access and linkages 
to ART including routine monitoring of the index cases for optimal adherence to their ART 
regimen. Finally, this collective treatment of prevention approach dictates that each component 
be implemented, i.e., simply increasing access to ART is not enough. To fully realize the 
prevention benefits evidenced in recent studies, ART for infected partners should be coupled 
with CHTC, prevention education and condoms as previously described. Moreover, social 
marketing can be harnessed as a strategy to improve delivery of an implemented treatment as 
prevention program, given social marketing’s proven reputation for enhancing delivery of public 
health interventions, to improve health outcomes and eventually turn the tide on new HIV 
infections (Newton-Ward, 2013a). Areas for future research have been identified which would 
also facilitate enhanced implementation of the proposed recommendations.  
These recommendations presented are globally relevant but were discussed in the context 
of a South African Case Study for greater clarity and more manageable application. South Africa 
serves as an ideal environment for treatment as prevention program focused on heterosexual 
discordant couples. Narrowing the focus of such a complex set of recommendations affords an 
opportunity to critically consider the associated benefits and barriers to such a plan on a smaller 
scale. Following evaluation and application of lessons learned, these recommendations could be 
tailored to discordant couples in different geographic areas as well as to different subpopulations.     
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Appendix 
Outline of Proposed Application of Social Marketing Strategies for Implementation of 
Recommendations in South Africa 
 
An preliminary outline of proposed marketing components including product, price, place 
and promotion offerings is presented below which can be applied as a first step to create 
facilitators which make adoption of the suggested behavior, i.e., participation in a comprehensive 
treatment as prevention program, seem necessary, reasonable, easy, and acceptable to 
heterosexual discordant couples (Newton-Ward, 2013a).  
Product Marketing Strategy 
Many discordant couples do not engage in HIV testing, use condoms or ART as 
prevention due to low perceptions of risk for HIV transmission or they assume they share the 
same HIV infection status, thus making the product marketing strategy critical. Lee & Kotler 
describe the product or service as “a mechanism that enables the target audience to translate their 
motivation into action” (2011, pg. 248). For the proposed treatment as prevention program, the 
core service is the CHTC, where couples receive education, counseling and testing for HIV and 
learn how to minimize HIV transmission using the core products of condoms and access to ART. 
Once educated and motivated, these products and services, along with the other marketing 
components, give discordant couples control to treat and prevent HIV, and safeguard their health. 
Price Marketing Strategy 
Price is defined as “the cost that the targeted audience associates with adopting the 
desired behavior” and the cost can be both monetary and nonmonetary in nature (Lee & Kotler, 
2011, pg. 268). ART is a priceless commodity for treating HIV and prevention as treatment in 
discordant couples. As previously described, access issues related to price should not be an issue 
in South African given the government provides ART for free or very low cost due to price 
 
 
40 
 
negotiations, subsidies and donations. Inexpensive items such as male and female condoms 
should be provided for free or low cost at CHTC, clinics and pharmacies. CHTC must be 
affordable, and ideally free, given it’s the key entry point for HIV treatment and prevention for 
discordant couples. Other costs such as transportation to CHTC and clinics for ART and time off 
from work can be mitigated by offering subsidized transportation tickets or vouchers and 
implementing policies which allow penalty-free time off from work (SANAC, 2011). Non-
monetary costs are more intangible, e.g., time and discomfort, are part of the previously 
described barriers influencing decisions (Lee & Kotler, 2011). If effective CHTC can be 
leveraged to overcome barriers to testing and disclosure, many of the intangible costs, e.g., 
psychological and physical threats, can be minimized.  
Programs can also offer incentives to encourage adoption and adherence of behaviors. A 
possible incentive is the use of conditional cash transfers for various HIV prevention behaviors if 
the uninfected partner in the couple remains uninfected. This type of strategy has been used to 
encourage females, to stay HIV negative by adopting various behaviors (UNAIDS, 2013; 
SANAC, 2011). Another potential incentive is tax breaks for HIV prevention efforts for 
discordant couples. Although originally proposed to increase marriage rates in South Africa, the 
concept may be relevant in this setting. These incentives provide benefit by encouraging HIV 
prevention as well as providing social structural support (SANAC, 2011). However, these 
incentives need to be carefully considered given gender inequality issues which often exist 
within couples and the need to protect human rights issues regarding testing (Gay et al., 2012).  
Place Marketing Strategy 
Lee & Kotler define the place marketing component as “where and when the target 
audience will perform the desired behavior, acquire any related goods, and receive any 
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associated services” (2011, pg. 291). Place marketing strategies should focus on making 
locations: closer, with extended hours, the point of decision making, where people feel more at 
ease, channels for overcome psychological and physical barriers or perhaps familiar distribution 
channels (Lee & Kotler, 2011).  
The CHTC serves as the “point of decision making,” a springboard for educating couples 
about discordance and the need for HIV testing as well as guiding couples to engage in the other 
recommendations of concerning condom use and how ART can treat and prevent transmission to 
the uninfected partner. For these reasons, the place marketing strategy is especially critical for 
eliminating CHTC related barriers (Kelley et al., 2011).  
Some CHTC can likely be conducted using existing clinics and prevention programs but 
with trained counselors adept at working with couples (Kelley et al., 2011). To overcome logistic 
issues, clinics and programs should offer extended hours to circumvent the couples’ work and 
life commitments (Katz et al., 2009). Incorporating CHTC as part of existing services may 
facilitate normalizing CHTC and overcoming fear of joint testing (Kelley et al., 2011). Other 
channels for testing include partnering with community based organizations (CBO) and faith 
based organizations (FBO) to deploy program counselors who can utilize these facilities and 
coordinate with their members and activities (CDC, 2012). CBOs and FBOs are important 
channels of support as they will facilitate the dialogue about HIV in a non-clinical setting.   
 Another potential place to encourage CHTC is in the couples’ homes via mobile testing 
sites which travel door-to-door through community targeted CHTC (Kelley et al., 2011). Home-
based CHTC can be critical for those in rural settings where transportation and time away from 
work or family is a barrier (Gay et al., 2012). Home-based CHTC may also be a good option 
given some communities may have limited resources and are unable to set up permanent 
 
 
42 
 
facilities or staff. Moreover, the stigma, fear and discrimination often associated with HIV may 
make in home testing more attractive due to privacy issues (Wong, 2013).   
Another reasonable access channel for CHTC is the workplace through partnership with 
highly trained counselors. The Siyazi Project is one such example in successful practice at 135 
sites via a partnership supported by Jhpeigo, the US CDC, South Africa, and various private and 
public partnerships, resulting in 60,000 South Africans receiving HCT services at their 
workplace (Jhpeigo Corp, 2013). This project encourages companies to include HCT for 
employees and their families as part of routine wellness programs. This type of investment can 
enhance employee health, productivity and overall welfare and perhaps could be modified to 
target couples. Importantly, this type of counseling helps decrease stigma and encourages 
workers to “test, know and plan your life” (Jhpiego Corp., 2013). Finally, this project links 
individuals and their partners to testing, counseling and HIV support groups.   
CHTC will be a viable place for couples to access condoms as will clinics and 
pharmacies. At distribution sites, condoms should be placed in easily accessible locations with 
promotional signage emphasizing condoms are for long term couples. Beyond CHTC, these 
couples will need convenient and affordable places to access their provision of ART. South 
Africa is already working on new policies and infrastructure to increase access to HIV care 
services at local health clinics versus requiring patients (and their partners) to travel to 
inconvenient places (Beaubian, 2013). Programs may consider partnering with CBOs to serve as 
a place for distribution of ART and other HIV-related care (Kennedy et al., 2010).  
Promotion Marketing Strategy 
 The promotional marketing component is defined as “the persuasive communications 
designed and delivered to inspire [the] target audience to action,” or more specifically the tools 
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for highlighting the products and services benefits and incentive and show to access them (Lee & 
Kotler, 2011, pg. 319). The promotional messages associated with these types of collective 
recommendations should communicate standardized but targeted messages which seek to 
increase couples perceived threat of HIV, as well as the “how” and “where” of accessing CHTC. 
Messages should explain the significance of discordance and the implications of treatment of as 
prevention strategies to maintain their partner’s uninfected status (Kelley et al., 2011). Moreover, 
promotional messaging should be geared towards increasing the perceived benefits of CHTC and 
keeping both partners healthy with ART. Essential to this messaging is highlighting how the 
other marketing strategies of product, price and place can decrease barriers to accessing these 
services. Although the collective recommendations previously described are reasonable in 
theory, these couples may be facing tremendous stigma and years of unchartered territory; thus it 
is essential that the couples perceive that the benefits outweigh their barriers so they can adopt 
these behaviors in their real lives.  
In terms of messengers, CBOs and FBOs can supplement the work of program 
messengers by acting as a non-clinical voice in favor of these collective recommendations. The 
CBOs and FBOs maintain a unique position by emphasizing benefits even in the reality of these 
couples’ current settings. CBOs and FBOs can also effectively address misinformation and 
beliefs specific to each community context and reduce stigma. As trusted entities, these leaders 
can guide couples to places where they can access easy to understand facts about HIV and 
emphasize the prevention impact of CHTC, condoms and ART (Kelley et al., 2011).  
Mass and social media, e.g., advertisements via radio, text messages, and billboards, can 
be harnessed to distribute information but also acknowledge the presence and relevance of 
discordant couples, emphasize CHTC, reduce stigma of HIV and encourage condom use and 
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ART for treatment and treatment as prevention (Kelley et al., 2011). Finally, it is critical to 
equally target men and women given their societal roles, gender issues, need for collective buy-
in and for normalization in discussing these issues (Harrison et al., 2006; Katz et al., 2009).  
Next Steps 
The preliminary social marketing outline presented here provides examples of possible 
product, price, place and promotion strategies to encourage heterosexual discordant couples’ 
uptake and adherence to a treatment as prevention program. However, it will be critical to 
develop and deploy a comprehensive social marketing plan which strategically links the 
marketing mix elements rather than utilizing each component as distinct strategies (Lee & 
Kotler, 2011). In order to accomplish this goal, detailed formative research should be conducted 
which is inclusive of the diverse geographic, socioeconomic and cultural groups comprising the 
larger target audience of discordant couples. Without such formative research and incorporation 
of tailored marketing mixes for various groups, there is a high risk of developing a social 
marketing campaign which caters to what developers believe the audience values and needs 
instead of identifying what program facets best serve this subpopulation (Lee & Kotler, 2011).  
